GMO: Genetically Modified Organisms as source of biotech drugs
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Presentation
- By: ODA, Leila Macedo (ANBio, Rio E Janeiro, Brazil)
Beginning in the early 1970s, advances on molecular biology and genetic engineering have led to enormous progress on the ability to understand of the bio-molecular route of human diseases. Paul Berg first produced the r-DNA in 1972 and this led the first transformation of Escherichia coli cells in 1973. It was founded the basis for genetic.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.